TY - JOUR
T1 - C11 choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails
AU - Saha, Sujata
AU - Vierkant, Robert A.
AU - Johnson, Geoffrey B.
AU - Parvinian, Ahmad
AU - Wermers, Robert A.
AU - Foster, Trenton
AU - McKenzie, Travis
AU - Dy, Benzon
AU - Lyden, Melanie
N1 - Funding Information:
Mayo Clinic receives funding to support research conducted by Geoffrey B. Johnson, MD, PhD, from Pfizer, Lantheus/Progenics, Endocyte/AAA/Novartis, Clarity, Clovis, Blue Earth, Curium, AstraZeneca, Beyer, Viewpoint, MedTrace, and Janssen. The first 10 C 11 choline PET/CT scans performed in the timeframe of this study were funded by the Mayo Clinic using a Nuclear Medicine Innovation Grant.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Focused parathyroidectomy in primary hyperparathyroidism is possible with accurate preoperative localization. A growing body of data exists regarding the role of radio-labeled C11 choline positron emission tomography/computed tomography. In cases of nonlocalized disease, it may be a useful adjunct to ultrasound, (123)I/(99)Tc-sestamibi (I-123 sestamibi), or 4-dimensional computed tomography imaging. Methods: Patients who received a neck and chest limited coverage C11 choline positron emission tomography/computed tomography for evaluation of primary hyperparathyroidism from 2017 to 2021 at a single institution were retrospectively reviewed. We assessed the sensitivity, positive predictive value, and false negative rate. We also compared these rates to the standard modalities of ultrasound, I-123 sestamibi, 4-dimensional computed tomography, and examined concordance rates. Results: We identified 43 patients, of whom 33 had a positive C11 choline positron emission tomography/computed tomography finding. This cohort of patients had failed to localize on multiple standard imaging modalities. Twenty-five patients proceeded to surgery, 72% of whom were reoperative cases. Twenty (80%) achieved an intraoperative cure. Analysis showed that C11 choline positron emission tomography/computed tomography achieved a sensitivity of 64% (95% confidence interval 47%–82%) and positive predictive value of 72% (95% confidence interval 54%–90%). There were 5/25 (20%) false positive positron emission tomography C11 choline results found to be lymph nodes, normal parathyroid, and 1 recurrent laryngeal nerve neuroma. Conclusion: C11 choline positron emission tomography/computed tomography is a useful adjunct for parathyroid localization in a complex population of patients who have failed standard localization techniques including ultrasound, I-123 sestamibi, or 4-dimensional computed tomography and/or prior operations. Although routine inclusion of C11 choline positron emission tomography/computed tomography imaging may not be necessary, it may aid in preoperative localization in the reoperative setting.
AB - Background: Focused parathyroidectomy in primary hyperparathyroidism is possible with accurate preoperative localization. A growing body of data exists regarding the role of radio-labeled C11 choline positron emission tomography/computed tomography. In cases of nonlocalized disease, it may be a useful adjunct to ultrasound, (123)I/(99)Tc-sestamibi (I-123 sestamibi), or 4-dimensional computed tomography imaging. Methods: Patients who received a neck and chest limited coverage C11 choline positron emission tomography/computed tomography for evaluation of primary hyperparathyroidism from 2017 to 2021 at a single institution were retrospectively reviewed. We assessed the sensitivity, positive predictive value, and false negative rate. We also compared these rates to the standard modalities of ultrasound, I-123 sestamibi, 4-dimensional computed tomography, and examined concordance rates. Results: We identified 43 patients, of whom 33 had a positive C11 choline positron emission tomography/computed tomography finding. This cohort of patients had failed to localize on multiple standard imaging modalities. Twenty-five patients proceeded to surgery, 72% of whom were reoperative cases. Twenty (80%) achieved an intraoperative cure. Analysis showed that C11 choline positron emission tomography/computed tomography achieved a sensitivity of 64% (95% confidence interval 47%–82%) and positive predictive value of 72% (95% confidence interval 54%–90%). There were 5/25 (20%) false positive positron emission tomography C11 choline results found to be lymph nodes, normal parathyroid, and 1 recurrent laryngeal nerve neuroma. Conclusion: C11 choline positron emission tomography/computed tomography is a useful adjunct for parathyroid localization in a complex population of patients who have failed standard localization techniques including ultrasound, I-123 sestamibi, or 4-dimensional computed tomography and/or prior operations. Although routine inclusion of C11 choline positron emission tomography/computed tomography imaging may not be necessary, it may aid in preoperative localization in the reoperative setting.
UR - http://www.scopus.com/inward/record.url?scp=85139722353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139722353&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2022.08.024
DO - 10.1016/j.surg.2022.08.024
M3 - Article
C2 - 36229257
AN - SCOPUS:85139722353
SN - 0039-6060
VL - 173
SP - 117
EP - 123
JO - Surgery (United States)
JF - Surgery (United States)
IS - 1
ER -